Physician profile
Jaymie Bailey
NPI 1821662347
$4,164.32
in general payments reported to CMS, 2019-2025
26 companies · $747 in 2025
The $747 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $348 · 2022: $1,332 · 2023: $679 · 2024: $1,058 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,484.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $663.76 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $439.99 | 2022-2025 | |
| Novo Nordisk INC | $314.20 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Medtronic, INC. | $301.97 | 2023 | Azure Xt Dr Mri Surescan, Micra |
| E.R. Squibb & Sons, L.L.C. | $287.91 | 2022-2024 | Camzyos, Eliquis |
| Boston Scientific Corporation | $230.76 | 2021-2025 | Bodyguardian, Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals Lp | $197.61 | 2021-2024 | Farxiga, Andexxa |
| Esperion Therapeutics, INC. | $184.42 | 2021-2024 | Nexletol |
| Abiomed | $183.66 | 2024-2025 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $167.30 | 2022-2025 | |
| Heartflow, INC. | $153.06 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $147.56 | 2024 | Inpefa |
| Pfizer INC. | $132.59 | 2021-2024 | |
| Bolton Medical INC | $127.94 | 2025 | Thoraflex Hybrid |
| Amgen INC. | $106.90 | 2024-2025 | Repatha, Repatha |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $99.84 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.12 | 2024-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.21 | 2021-2022 | |
| Cvrx, INC. | $61.81 | 2025 | Barostim Neo System |
| Abbvie INC. | $42.23 | 2021 | |
| United Therapeutics Corporation | $36.72 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $29.10 | 2025 | Optimizer |
| Edwards Lifesciences Corporation | $27.62 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bridgebio Pharma, INC. | $22.68 | 2025 | Attruby |
| Lantheus Medical Imaging, INC. | $18.51 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.85 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaymie Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.